WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Elton Satusky
Partner
Corporate
Palo Alto
esatusky@wsgr.com

D650-565-3588

Download vCard
Open PDF
  • Extensive Corporate Experience

    Elton specializes in public and private corporate finance and corporate law and governance, and also has considerable M&A and venture capital experience.

  • Life Sciences Insider

    Elton serves as co-editor of The Life Sciences Report, a semi-annual newsletter on the life sciences industry published by the firm.

Elton Satusky is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. Elton represents both public and private enterprises as their outside general counsel and serves as a key strategic advisor from their inception throughout their life cycle. He advises on complex venture capital and corporate finance transactions, corporate law and governance, mergers and acquisitions, and public offerings. 

Elton has a particular focus on companies in the medical device, biotechnology, pharmaceutical, diagnostic, and digital health sectors and serves as co-editor of The Life Sciences Report, a semi-annual newsletter on the life sciences industry published by the firm. He is also a board member and founder of US-Japan Medtech Frontiers, a nonprofit corporation that has hosted annual cross-border healthcare conferences in Japan for the past decade. In addition, Elton is a frequent guest lecturer at universities, industry and trade group conferences, accelerators, and incubators.

Experience

Elton Satusky is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. Elton represents both public and private enterprises as their outside general counsel and serves as a key strategic advisor from their inception throughout their life cycle. He advises on complex venture capital and corporate finance transactions, corporate law and governance, mergers and acquisitions, and public offerings. 

Elton has a particular focus on companies in the medical device, biotechnology, pharmaceutical, diagnostic, and digital health sectors and serves as co-editor of The Life Sciences Report, a semi-annual newsletter on the life sciences industry published by the firm. He is also a board member and founder of US-Japan Medtech Frontiers, a nonprofit corporation that has hosted annual cross-border healthcare conferences in Japan for the past decade. In addition, Elton is a frequent guest lecturer at universities, industry and trade group conferences, accelerators, and incubators.

Education
  • LL.B., Osgoode Hall Law School, York University, Toronto, 1996
  • Two years towards Bachelor of Business Administration, York University, Toronto, 1993
Admissions
  • Law Society of Ontario
  • State Bar of California
Credentials
Education
  • LL.B., Osgoode Hall Law School, York University, Toronto, 1996
  • Two years towards Bachelor of Business Administration, York University, Toronto, 1993
Admissions
  • Law Society of Ontario
  • State Bar of California
Focus Areas
  • Biotech
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Corporate Life Sciences
  • Digital Health
  • Emerging Companies and Venture Capital
  • Internet
  • Life Sciences
  • Mergers & Acquisitions
  • Mobile Devices
Recent Insights
Client Highlights
Firm Advises Noctrix on Acquisition by Resmed
On June 1, 2026, Resmed, a medical device company that develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders, announced it has closed on its acquisition of Noctrix Health, a medical device company that developed and manufactures a novel therapy to treat drug-refractory Restless Legs Syndrome (RLS) for $340 million. Wilson Sonsini Goodrich & Rosati advised Noctrix on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises HexemBio on $10.4 Million Seed Round
On April 7, 2026, HexemBio announced its public launch as a biotechnology company developing the breakthrough blood stem cell rejuvenation therapy, alongside the close of a $10.4 million seed round. The round is led by Draper Associates with participation from SOSV, Seraphim, and other strategic investors. The funding will be used to finalize HexemBio’s IND-enabling studies and GMP manufacturing, with the company targeting first-in-human trials in 2027. Wilson Sonsini Goodrich & Rosati advised HexemBio on the transaction.
Learn More
View All
Recent Events
Speaking Engagements
Roadmap to a Successful Series A - Platform vs. Single Asset vs. Pipeline
On Thursday, May 14, partner Elton Satusky will join the "Platform vs. Single Asset vs. Pipeline" panel, which is the first session of the "Roadmap to a Successful Series A" six-part series hosted by Biocom.
Learn More
Speaking Engagements
Canadian Entrepreneurs in Life Sciences (CELS) Valley Ready Program
Wilson Sonsini is proud to partner with CELS - Canadian Entrepreneurs in Life Science to host the Valley Ready (VR) Program, an exclusive opportunity to engage directly with high-potential Canadian life sciences companies as they prepare to scale into the U.S. market. Designed for health science scale-ups that have completed a Pre-Seed or Seed round, this 2 day program immerses founders in the dynamic Bay Area ecosystem, connecting them with top investors, mentors, and industry experts.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.